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Neuroprotection With Anesthetics in Two Models of Cerebral Ischemia 
 
Rafael Eduardo Chaparro Buitrago, M.D. 
 
ABSTRACT  
Neuroprotection with anesthetics has been studied for many decades; 
important advances in this field have modified the way Anesthesiologists treat 
patients in the operating room. Animal models have played an important role in 
the study of ischemia in the operating room. Recent studies have demonstrated 
that the effect of anesthetics seems to be different in different animal models. We 
decided to evaluate anesthetics in a well-known model of cerebral ischemia and 
also in hypotensive models designed by us. We used a model of cerebral 
ischemia (MCAO) to test anesthetics neuroprotective effect in a two-week period. 
Then, we used a model of hypotension to characterize the damage caused by 
this type of insult. Finally we characterized a model of hypotension plus hypoxia 
that can mimic real situations in the OR. 
We found that anesthetics alone do not have a neuroprotective effect after 
two weeks in the MCAO model; but the combination of anesthetics with caspase 
  vii 
inhibitors can decrease the damage caused by ischemia. The caspase inhibitor 
by itself did not show a significant neuroprotective effect.  
We also found that repetitive periods of profound hypotension can cause 
important damage in the hippocampus but no memory or neurological changes 
were seen. The induction of only one episode of hypotension plus hypoxia did 
not alter the morphology of the hippocampus although induced memory changes 
that were reverted by the use of anesthetics. 
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INTRODUCTION: 
 
Perioperative neuronal injury. 
Neuronal injury during anesthesia although infrequent, can result in 
subclinical neurocognitive deficit, long term disability or even death. The insult is 
caused by ischemia or hypoxia. Recent implementation of different 
neuroprotective maneuvers has reduced neurological morbidity and mortality. 
Several surgical procedures are more likely to cause brain injury (1). For this 
reason clinicians have been identifying these procedures and exploring possible 
neuroprotective therapies for more than six decades (2). 
 Pathophysiology of Ischemic Cerebral Injury:  
Ischemia is defined as a local or global and temporary deficiency of blood 
supply, which may be accompanied by consequent cell alterations. In humans a 
normal cerebral blood flow (CBF) is accepted as a blood flow between 45 to 50 
ml/min/100g of tissue, which is usually generated by a mean arterial pressure 
between 60 to 130 mmHg. If the CBF drops below 20 to 30 ml/min/100g of tissue 
the cerebral cortex is considered ischemic. 
Cerebral ischemia can be localized (focal ischemia) or generalized (global 
ischemia). Macroscopically they have different characteristics but the 
pathophysiology at the cellular level is similar. In focal ischemia the sudden loss 
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of cerebral blood flow causes immediate necrosis. This area is called “ischemic 
core”.  Around the core lies another region called the “ischemic penumbra”; in 
this region there is a proliferation of apoptotic cells.  If uncorrected the ischemic 
damage will cause these cells to die in a few weeks increasing the size of the 
infarct (3,4) as shown in Figure1. 
 
 
 
 
 
Figure 1. Macroscopic pathology of focal Ischemia. Early in the course of 
the lesion, the necrotic component (core) is the most important factor. Over 
time, the penumbra area is responsible for the growth of the lesion (5). 
 
 
Neurotransmitters are implicated in the pathogenesis of ischemic cell 
injury, especially glutamate and GABA (6,7). After ischemia there is depletion in 
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energy stores. This depletion can lead to acidosis, failure of the Na+ / K+ pump 
which produces membrane depolarization and/or an excessive release of 
glutamate into the synaptic cleft. Glutamate activates N-methyl-d-aspartate 
(NMDA) and α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) 
receptors in the postsynaptic neuron. These receptors activate the voltage gated 
calcium channels and in consequence there is an increase in the intracellular 
calcium. High intracellular Ca++ levels produces activation of nitric oxide 
synthetase (NOS), lipases, proteases and endonucleases. From here, two 
pathways can be activated. First, apoptosis can lead to an irreversible cell 
damage and cell death. The other pathway implicates NOS. Increased 
production of nitric oxide (NO) and free radicals can lead to lipid peroxidation, 
also causing irreversible cell damage and cell death. In some cases the ischemic 
injury is not sustained and reperfusion occurs. When this happens, besides the 
formation of free radicals, there is also inflammation with a subsequent cytokine 
release and irreversible cell damage and cell death (4,8-10). These pathways are 
depicted in Figure 2. 
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Figure 2. The neurodegenerative cascade (5). Ischemia leads to cell death 
after cerebral ischemia through a series of intermediate steps. 
In the penumbra area cells are mostly apoptotic.  Apoptosis is defined as 
programmed cell death in multicellular organisms. It is widely recognized that 
there are three apoptotic pathways.  Two are caspase dependent and one is 
caspase independent. The first caspase dependent pathway is called the intrinsic 
pathway, and is the mitochondrial mediated pathway.  The second one is a 
receptor mediated cascade and is called the extrinsic pathway (11).  
The exact mechanism of activation on both pathways is not exactly 
known, but the cascade after activation has been described. In the intrinsic 
pathway cythochrome C is released from the mitochondria. Pro-apoptotic Bax 
proteins induce cytochrome C release by opening the voltage dependent anion 
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channels (VDAC) allowing cytochrome C to pass through the channel. Bcl-2 and 
Bcl-XL proteins have the exact opposite effect. They close the VDAC channels 
and in this way prevent apoptosis. The cytochrome C activates procaspase 9 and 
converts it to activated caspase 9. At this point the intrinsic and extrinsic pathway 
merge into the common pathway and activate procaspase 3 converting it to 
activated caspase 3. This caspase will cause cellular death (12,13). The extrinsic 
pathway is a receptor mediated pathway. It is activated when the Fas receptor 
(Fas-R) receives the Fas ligand (Fas-L). The Fas-R is a type two transmembrane 
protein that is part of the tumor necrosis factor (TNF) family. The Fas associated 
protein with death domain (FADD) is a molecule that serves as a bridge between 
the Fas-R and the procaspase 8, converting it to activated caspase 8. After this 
point the extrinsic pathway merges with the common pathway and activated 
caspase 8 activates procaspase 3 resulting in apoptosis (14,15). The caspase 
independent pathway is mediated by the apoptosis inducing factor (AIF) released 
from the mitochondria. This factor induces apoptosis without using caspase 
proteins (8).  
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Figure 3. Signaling pathway of ischemia induced apoptosis (8). Three 
pathways culminating in apoptosis are depicted. 
 
Hypotension. 
Hypotension has been defined by the World Health Organization as a 
systolic pressure below 110 mmHg in males and 100 mmHg in females. Diastolic 
pressure is not taken into consideration (16). Chronic hypotension in humans is 
responsible for a variety of symptoms like fatigue, dizziness, palpitations and 
even cognitive alterations. Chronic hypotension does appear as damaging (17) 
and there are autoregulatory mechanisms that protect specific organs against its 
effects. Recent data suggests that hypotension is responsible for alterations in 
cognitive performance (17,18). Some researchers have demonstrated that even 
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short periods of profound hypotension can cause cell damage in animal studies 
(19). 
During hemorrhagic hypotension, intravascular volume is lost and 
regulatory mechanisms rapidly start compensatory mechanisms. The first event 
occurs in the heart. Lack of volume causes a decrease in cardiac output. The 
body reacts by decreasing the blood supply to organs with less oxygen 
consumption like skin, intestines or muscle, while preferential flow is shifted to 
the brain and the heart. Immediate vasoconstriction caused by local mediators 
tends to stop bleeding and this mechanism is reinforced by an activation of the 
sympathetic system that causes more vasoconstriction and also an increase in 
cardiac output. When hypotension persists for long periods or when profound 
hypotension is present these mechanisms are not sufficient to maintain cell 
viability and the cells die by necrosis or apoptosis (20). 
 Cognitive dysfunction has been linked with hypotension(17,21), especially 
in elderly patients(22-24). Several studies have studied the relation between 
hypotension during surgery and neurological performance after surgery but so far 
a clear link has not been found(25). The largest study that evaluated this point 
was “The International Study of Postoperative Cognitive Dysfunction” but an 
association between surgical blood pressure and postoperative cognitive 
dysfunction was not found(26). In contrast, other researchers have found a clear 
overall link between surgery and blood pressure during surgery (18,26,27).  
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Another important concept for the purpose of this presentation is hypoxia 
reduction in O2 availability to tissue. This can be caused by a variety of 
respiratory or circulatory factors.  
There are direct and indirect measures to evaluate oxygen in the blood.  
One of the indirect indexes is the pulse oximeter, a device that measures the 
oxygen saturation. Normal ranges are from 95% to 100%, while values below 
90% are considered hypoxic. A direct measurement can be made with arterial 
blood gases analysis: which measures pO2 values. The normal range is between 
80 to 100 mm Hg. During ischemia or hypotension, hypoxia is the main critical 
factor since low levels of oxygen are responsible for cell injury. All living carbon 
based organisms use oxygen for their metabolism. When cells do not receive 
enough oxygen they enter in an inefficient anaerobic state and if this situation is 
maintained for long periods they will die. After the hypoxic insult there is an 
increase in intracellular calcium that can lead either to necrosis or apoptosis (28) 
Anesthetics and neuroprotection with anesthetics. 
Anesthetics have been shown to decrease ischemic/hypoxic cerebral 
injury, but their action only last for short periods of time. This principle is correct 
in some types of injury but not in others, so the purpose of this review is to study 
the typical anesthetics and their actions in different models of cerebral 
ischemia/hypoxia. There are two anesthetics that have been studied widely as 
neuroprotective agents, propofol, an intravenous anesthetic and isoflurane, an 
inhalational anesthetic.  
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Propofol (2,6-diisopropylphenol) is a nonbarbiturate intravenous general 
anesthetic; Propofolcan be used alone with a continuous infusion or in 
combination with inhalational anesthetics. Propofol can induce anesthesia more 
rapidly than barbiturates and recovery is a lot faster and devoid of side effects. Its 
mechanism of action is not well understood but the data suggests that propofol is 
a GABAA receptor agonist and also has inhibitory action at the glutamate NMDA 
subtype receptor. Propofol is also used to treat other pathologies like status 
epilepticus, delirium tremens and refractory migraines; these uses are 
considered a consequence of its glutamate antagonism or its GABA antagonism. 
Propofol decreases intracranial pressure, decreases cerebral oxygen 
consumption, increases cerebrovascular resistance and decreases cerebral 
blood flow.  In addition, propofol also has antiemetic properties by reducing 
serotonin concentration in the dorso-lateral reticular formation. Also propofol has 
been shown to attenuate neuronal injury (29).  
The dosage used depends on the type of procedure, age of the patient or 
the pathology that is being treated. For induction in adult neurosurgical patients, 
slow administration is recommended using bolus of 20 mg every 10 seconds. 
Slower boluses or infusion of propofol for induction of anesthesia, titrated to 
clinical response, will generally result in reduced induction dosage requirements 
(1 to 2 mg/kg). Maintenance dosage is 100 to 200 microgr/kg/minute (6 to 12 
mg/kg/hour) IV (30). 
Isoflurane is a general anesthetic, classified as halogenated anesthetic, 
and is a nonflammable colorless liquid that requires a vaporizer for its clinical 
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use. Isoflurane provides a rapid induction and rapid recovery. It is also a muscle 
relaxant, a very useful characteristic in the operating room. The mechanism of 
action is unknown but some studies suggest that isoflurane can alter the 
membrane function by decreasing the number of molecules that alternate 
between gel and crystalline states (30). After inhalation, isoflurane is absorbed by 
the pulmonary capillary system. It undergoes little biotransformation. Almost 95% 
is exhaled unchanged, and only 0.17% is found in urine as metabolites. The 
minimum alveolar concentration for an adult man is 1.15% but this decreases 
with age. For induction in adults the recommended dose is 1.5 to 3%, which 
induces, anesthesia in 5 to 10 minutes. Anesthesia maintenance in adults is 1.5 
to 3.5% when inhaled in oxygen. In children 0.5 to 1.5% is the recommended 
average dosage. For induction, the concentration of isoflurane should not be 
higher than 3% and no more than 2.5%, in children (30). 
Neuroprotection with anesthetics is a practice that has been used for 
almost sixty years (1). The first anesthetics used for this purpose were the 
barbiturates, and their neuroprotective activity was attributed to a reduction in the 
metabolic rate.  Research has shown that the anesthetics go even further and 
have specific actions on specific receptors. The majority of anesthetics have an 
antagonistic effect on the glutamate receptors (NMDA and AMPA). Some 
researchers also believe that anesthetics can increase reuptake and decrease 
the release of glutamate in the presynaptic neuron. Additionally, anesthetics have 
an agonistic effect on GABAA receptors increasing itheir inhibitory activity. As a 
result, a decrease in the intracellular Ca++ may block the deleterious effects of 
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ischemia/hypoxia (1,31-33). Bickler et al (2006); have demonstrated that 
protection of hypoxic cortical neurons with anesthetics more specifically 
isoflurane, involves signaling that includes changes in intracellular Ca++ 
regulation, several MAP kinase pathways and modulation of apoptosis regulators 
(34).  
There are also two pore domain potassium channels KC (K2P) that 
provide regulation of membrane potential. These TREK channels are present in 
the central nervous system and are activated by acidosis, temperature, 
polyunsaturated fatty acids, membrane stretch and also by volatile anesthetics. 
These channels have neuroprotective activity and their activation explains why 
some polyunsaturated fatty acids have neuroprotective actions (35).  
Brain relaxation is another one of the anesthetics’ properties useful in the 
operating room. This is very important in neurosurgery, especially in patients with 
intracranial hypertension caused by a reduced blood volume; relaxation is a 
neuroprotective measure in this type of patients. Also propofol is known as a 
drug that can reduce regional cerebral blood flow and metabolism, characteristics 
that are also known as neuroprotective (36,37). 
Anesthetics have been demonstrated to be protective only for two days 
post-ischemia in cases of severe focal ischemia, but this effect was not 
maintained at 14 days (38-40). This is probably due to the apoptotic activity in the 
penumbra area (38).  Anesthetics inhibit necrotic damage but are incapable of 
reducing apoptotic injury (39). It is also important to mention that anesthetics 
prevent necrotic injury only if they are administered during ischemia; they have 
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no action if administered after ischemia (41,42). Preconditioning with anesthetics 
is another practice that has shown to be effective in reducing ischemic injury 
(43).   
Anesthetics also have neuroprotective action if the ischemic injury is mild 
and although it does not produce necrosis, it can trigger apoptosis (44). If the 
ischemic insult is mild, anesthetics by themselves are protective enough and can 
decrease the neurologic morbidity (40). In the operating room, ischemic insults 
vary from temporary vessel occlusion to profound systemic hypotension. In 
general, insults tend to be temporal, mild and usually last for no more than 70 
minutes.  IT is generally accepted that ischemia lasting more than ten minutes 
causes brain damage and it is also accepted that in the presence of anesthetics 
this damage is substantially reduced (40). 
Recent publications have shown that anesthetics can act as a necrosis 
inhibitors and this action could buy some time to initiate therapies that modify 
apoptosis.  Some researchers have been studying apoptosis and antiapoptotic 
therapies as a possible treatment for cerebral injury (45). Kawaguchi et al (2006); 
used caspase inhibitors to prolong the neuroprotective effect of anesthetics in 
models of middle cerebral artery occlusion with positive protective results (46). 
However; unfortunately there are no proven antiapoptotic therapies available for 
humans. Sakai et al (2007); reported long-lasting protection by Isoflurane with no 
need for the use of caspase inhibitors (48) and provided good evidence that the 
difference with Kawaguchi et al (2004) was caused to the later using an MCAO 
model that integrated permanent carotid occlusion and thus persistent 
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hypoperfusion (38). On the other hand, Elsersy et al (2004) showed evidence of 
decline of the protective effect of Isoflurane over time; suggesting that the 
protection between local and global ischemia is different (47);.  
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Abstract: 
Introduction: 
Neuroprotection researchers have used caspase inhibitors to reduce 
neuronal damage caused by ischemia. Most of the trials have shown positive 
effects when these substances were administered intracranially (1).  
There is very limited evidence that caspase blockers can be used systemically 
and still have a beneficial effect. We hypothesized that caspase inhibitors could 
cross the hematoencephalic barrier during ischemic events like stroke.  
 
Materials and methods:  
To test our hypothesis we used 250 to 350g male Sprague Dawley rats of 
an average age of three months examined after MCAO+CCAO. The control 
group (group 1) received no treatment following the surgery (n=10).  Group 2 
received 90 minutes of 1% Isoflurane while inside an exposure chamber (n=7). 
Group 3 received 35 mg/kg/h of Propofoli.v. for 90 minutes (n=7). Group 4 
received the 1% Isoflurane treatment for 90 minutes followed by 3 systemic 
injections of a caspase 3 inhibitor (100 µg Z-DEVD-FMK, BD Pharmingen, San 
Jose, CA) that were given 3 times: immediately after, 24 hours after and one 
week after Isoflurane treatment (n=7). Group 5 received 35 mg/kg/h of 
Propofolfor 90 minutes followed by the same caspase 3 inhibitor treatment 
regimen as group 4 (n=6). Group 6 received only Caspase 3 inhibitor as 
described before (n=6).  Neuroscore evaluation was made on days 0, 4 and 14. 
Animals were euthanized two weeks after MCAO+CCAO. Brains were harvested, 
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sectioned, and a series of adjacent sections were stained for H&E, TUNEL and 
cleaved caspase-3. Infarct size as a percentage of the normal hemisphere was 
reported. The numbers of positively stained neurons were counted within the 
infarcted hemisphere using unbiased Stereology (Stereology Resource Center, 
Chester, MD).  Statistical analysis was performed using Graphpad Prism 5 with 
Bonferroni test at a 95% confidence interval, after ANOVA (* p<0.05). 
 
Results: 
The combination of Isoflurane plus a caspase 3 inhibitor significantly 
reduces the infarct size two weeks after the infarct; the rest of the groups did not 
show a statistically significant difference. The number of neurons that were 
positive for TUNEL were not significantly different in the groups that were treated 
with Propofoland Isoflurane alone compared to the control group. However, the 
number of positive TUNEL neurons were significantly lower in animals that 
received Z-DEVD-FMK in comparison with the animals that did not received the 
caspase inhibitor.  These results were confirmed with the significant reduction in 
cleaved caspase 3 positive neurons in the groups treated with the caspase 
inhibitors compared to the control group and the rats treated with anesthetics 
alone.  
Conclusion:  
Isoflurane plus systemic administration of caspase 3 inhibitor has a 
positive effect in the histological outcome of ischemic brains. With the significant 
reduction in apoptotic cells, we demonstrated that the caspase inhibitor can 
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reach intracerebral targets after intraperitoneal injections and block the apoptotic 
cascade, decreasing the deleterious effects of programmed cell death.
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Introduction: 
Neuronal injury during anesthesia although infrequent, can result in 
subclinical neurocognitive deficit, long-term disability or even death, being the 
insult usually due to ischemia, hypoxia or both. Innovative neuroprotective 
maneuvers have shown to decrease neurological morbidity and mortality. Some 
surgical procedures are more likely to cause brain injury (2), for this reason 
clinicians have been identifying these procedures and working in possible 
neuroprotective therapies for more than six decades (3). Researches have 
demonstrated that anesthetics can decrease the ischemic damage, in some 
cases the neuroprotective effect was only evident for short periods of time (4), in 
contrast; other researchers have found positive effects up to 8 weeks after the 
insult (5). Sakai et al; evaluated the effect of anesthetics in different models of 
ischemia and found that the effect of anesthetics can change depending on the 
model used to test the neuroprotective effect of the drugs (4,5). Independently of 
the model used, the histological damage increases day after day for extended 
periods of time and these changes can be divided in two stages: an early stage 
and late stage. Early changes are related to acute neuronal death mediated by 
glutamate activity and neuronal depolarization; and anesthetics like isoflurane 
have shown to be effective in blocking glutamate activity and neuronal 
depolarization (6-9). Delayed damage is caused mainly by apoptosis; however, 
other factors like inflammation play an important role. Researchers have used 
caspase inhibitors to block the apoptotic cascade with remarkable success (1,10-
12).  
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Researchers do not agree in how to manage the ischemic injury but in 
general there is an agreement that no single therapy is sufficient (13). We 
consider that the combination of an anesthetic plus caspase inhibitors can 
reduce brain damage compared with each therapy used alone. 
Materials and Methods. 
Regulations:  
The present study was presented, evaluated and approved by the division 
of Comparative Medicine at the University of South Florida (USF). The 
experiments were done in following the guidelines of the IACUC of the University 
of South Florida’s College of Medicine. 
  
 
 
 
Table 1. Study design Z-DEVD-FMK caspase 3 inhibitor from Biosciences 
pharmaceutical. IV = intravenus. DMSO: Dimethyl Sulfoxide. 
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The animals were divided in 6 groups as shown in table 1a. Animals were 
treated with anesthetics alone or in combination with caspase 3 inhibitors.  A 
group was treated only with the caspase inhibitor and all groups were compared 
with the controls. 
 
 
Table 2. Time course.The project was designed to evaluate the 
neuroprotective effect of anesthetics alone or in combination with caspase 
inhibitors in a 2 week period. 
 
Table 2 shows the specific order of occurrence of the events. Day 0 is the day of 
the surgery. 
 
Animals:  
Male Sprague Dawley rats from Harlan Laboratories (Indianapolis, IN), 
with ages between 60 to 90 days and weights between 250 to 350 grams were 
used for this experiment. Upon arrival to the USF College of Medicine Vivarium 
the rats were housed in a climate controlled room in plastic cages in groups of 
two with free access to water and food and were left in quarantine for a week 
before the experiment took place.  In general, all animals received the same 
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anesthesia for the vascular occlusion surgery (see description below). In addition 
the animals were divided in 6 groups:  
1. Control group, these animals received a Middle Cerebral Artery 
occlusion plus Common Carotid Artery Occlusion (MCAO + CCAO) with no 
treatment. 
2. Isoflurane group received 90 minutes of 1% Isoflurane and 100% 
Oxygen in a sealed chamber after the surgery. 
3. Propofol group received 90 minutes of Propofolintravenously (tail vein) 
at 35mg/kg/h after the surgery.  
4. Isoflurane plus caspase 3 inhibitor (C3I) group: received Isoflurane 1% 
and 100% Oxygen in a sealed chamber for 90 minutes after the surgery and C3I 
intraperitoneal100µg in Dimethyl sulfoxide (DMSO) 0.1ml. The caspase 3 
inhibitor used was Z-DEVD-FMK from DB Pharmingen (San Jose CA.), the 
animals were injected 3 times: immediately after the surgery, the next day after 
the surgery and a week after the surgery.  
5. Propofol plus C3I; received 90 minutes of Propofolintravenously (tail 
vein catheter) at 35mg/kg/h after the surgery plus C3I intraperitoneal100µg in 
(DMSO) 0.1ml intraperitoneal  3 times: immediately after the surgery, the next 
day after the surgery and a week after the surgery.  
6. C3I only, this group received the caspase 3 inhibitor after surgery with 
the same dosage and schedule as the other groups. 
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Neurological Assessment: 
We used a seven point neurological score to evaluate the animals (Table 
2) (1). The test was done at four different time points. The first evaluation was the 
day before the surgery. This test was performed to assure that neurologically the 
rats were intact. No animals were withdrawn from the study for failing this 
evaluation.  
 
 
Table 3.  Neurological score. All animals were evaluated before the surgery, 
at day one after the surgery and two weeks after the surgery (1). 
 The neurological evaluation was done in all the groups: one day after the 
surgery, four days after the surgery and fourteen days after the surgery.  Dead 
animals were not included in the neurological score; mortality information was 
recorded and is presented in the results section. 
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Anesthesia: 
After the weight was recorded, the animal was anesthetized in an 
induction chamber with 5% Isoflurane in 100% Oxygen. After the rat was fully 
anesthetized we changed the animal from the induction chamber to a mask with 
1 to 2% Isoflurane in 100% oxygen.  
Doppler Study: 
After shaving the head and neck, the animal was placed in a stereotactic 
frame. A sagittal incision was made to expose the skull; all the connective tissue 
was removed with a cotton applicator until the bregma was fully identified. A 
Dremel 400 Series XPR rotary tool was attached to the frame to precisely 
microdrill a hole at 1 mm posterior and 4 mm lateral to the bregma in the same 
hemisphere were the middle cerebral artery occlusion plus common carotid 
artery occlusion occurred. An intracerebral guide cannula from Harvard 
Biosciences Company was inserted in the hole and was sealed in place with 
dental cement; a Laser Doppler optic rigid prove (500µm) attached to a Laser 
Doppler monitor from Moor Instrumets LTD, was inserted into the guide cannula. 
The intracerebral blood pressure was then recorded using Laser Doppler, 
Windows compatible software from Moor Laboratories previously installed in a 
Dell computer.  
The animal was then taken off the stereotactic frame and placed on a 
custom made stainless steal surgical board from Calven de Oriente C.A. During 
the surgery we were looking for a sharp decrease in blood flow, the animals that 
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did not reach al least 50% decrease in blood flow were not included in the study. 
An average of 77% decrease in blood flow was recorded in the animals after the 
arterial occlusion. After the surgery, probe and cannula were removed and the 
skin sutured with a skin stapler. After the surgery the animal was placed in a 
fresh cage for recovery. 
Permanent Middle Cerebral Artery Occlusion plus Common Carotid Artery 
Occlusion: 
A medial incision on the middle line of the neck was done with a 15 blade 
scalpel, the common carotid, external carotid and internal carotid arteries were 
identified, and permanent ligation of the common carotid artery with a 4-0 silk 
was followed by an incision in the arterial bifurcation of the common carotid 
artery.  A 4 cm Ethicon 4-0 Prolene monofilament was inserted trough the arterial 
incision into the internal carotid artery and advanced until the middle cerebral 
artery was reached and resistance was felt. The tread was secured in place with 
a 4-0 silk. The skin was closed with a skin stapler (14). 
Physiological parameters: 
We measured physiological parameters to assure that the results we 
obtained were due to the treatment and could not be confused with alterations in 
physiologic changes. The variables we measured were: Weight, temperature 
taken with a rectal thermometer (a heated pad was used to maintain body 
temperature during the procedure); a pulse oximeter was used to measure 
hemoglobin saturation (Hb Sat); heart rate (HR) and blood pressure (BP) were 
taken directly from an arterial catheter placed on the femoral artery (SurgiVet 
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Advisor Monitor. Model number 92V303100 was used for Hb Sat, HR and BP); 
hematocrit was measured using Damon IEC MB Micro Hematocrit Desk-Top Lab 
Centrifuge. The measurements were taken before and after the ischemic event. 
Weight was measured right before the surgery and at day 14. 
Brain Collection and Sectioning 
The animals were euthanatized with an overdose of CO2; immediately 
after, the animal was perfused with normal saline solution 0.9% followed by 4% 
paraformaldehyde. The brains were harvested, stored in plastic tubes with 4% 
paraformaldehyde for 24 hours, and then changed to 10%, 20% and 30% 
sucrose every 24 hours. After that, brains were sectioned with a cryostat at 
50µm; sections were collected as soon as the infarct area appeared and two of 
every 5 sections were collected for TUNEL and Cleaved Capase 3 staining until 
the infarct area was no longer visible (15). A total of 5 to12 sections per brain 
were collected depending on the infarct size. Sections were stored in PBS plus 
Azide and then mounted for histopathology analysis. 
Hematoxylin and Eosin staining: 
H and E analysis was used to quantify the infarct size; the staining method 
used consisted in: 2 changes in absolute ethyl alcohol for 1 minute. Then, 2 
changes in 95% ethyl alcohol for 1 minute and wash in running tap water for 1-2 
minutes. Sections were immersed in Mayer's hematoxylin, for 5-10 minutes and 
then washed in running tap water for 10 minutes. Later submerged in working 
Eosin-Phloxine for 2-3 minutes. 2 more changes in 95% ethyl alcohol for 2 
minutes each with gentle agitation at each change. After that absolute ethyl 
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alcohol for 2 minutes. Clean in 3 changes of Xylene of 2 minutes each. Finally, 
coverslip directly from xylene (16). 
Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) 
staining: 
TUNEL was used to evaluate the effect of Z-DEVD-FMK, Caspase 3 
Inhibitor in the infracted hemisphere. ApopTag In Situ Apoptosis Detection Kit 
from Chemicon International, Temecula, CA., CAT. #: S7100-KIT was used 
following the instructions of the supplier.  
Cleaved Caspase 3 Staining: 
We used Cleaved caspase 3 positive cells to confirm that the Z-DEVD-
FMK injected intraperitonely reach specific targets in the brain.  
Permeabilize in ethanol/acetic acid, 2:1. Wash in 2 changes of PBS. Mounted 
slides were hydrated in graded ETOH washes to deionized water (5 minutes 
each). Antigen retrieval was performed using the heating method; sections were 
steamed in 0.1M citrate buffer, pH 6.0, for 25 minutes, and cooled for 20 minutes. 
The tissues were washed in PBS for 10 minutes, followed by quenching of 
endogenous peroxidase activity with 3% H2O2 wash for 10 minutes. The tissues 
were washed in PBS (3 x 5 minutes each) followed by a blockade of nonspecific 
protein binding with 10% normal goat serum, 2% BSA, PBS for 30 minutes at 
room temperature. The tissues were incubated in avidin for 15 minutes, followed 
by biotin for 15 minutes, and then incubated at Negative controls were incubated 
without the primary antibody. Following a PBS wash (4 x 5 minutes), the tissues 
were incubated with the secondary antibody (biotinylated anti-rabbit IgG) at 
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room temperature for 30 minutes. Following a PBS wash (4 x 5 minutes each), 
the tissues were incubated with Vector ABC (elite Kit) for 20 minutes at room 
temperature. Following a final PBS wash (4 x 5 minutes each), the sections were 
incubated in a DAB substrate for visualization of the peroxidase-reaction. The 
sections were washed in deionized water (5 minutes), counterstained, and 
dehydrated (graded ETOH, 5 minutes each step). Sections were then washed in 
xylene (3 x 5 minutes each) and coverslipped with permount.(15) 
Statistical Analysis: 
The data are presented as Mean ± SE. To measure the infarct size and 
count the number of TUNEL and Cleaved Caspase 3 positive cells we used 
unbiased stereology (17) (Cavalieri estimator and optical dissector respectively) 
measured with the Stereologer from Stereology Resource Center, Chester, 
Maryland. We evaluated the volume of the infarct and also the volume of the 
opposite hemisphere; results are presented as a stroke area as percentage of 
the area of the opposite hemisphere to compensate for edema.  The results were 
analyzed using GraphPad Prism 5.0 for Mac. Analysis of Variance was follow by 
Fisher LSD formula. 
To quantify the number of TUNEL and Cleaved Caspase 3 positive cells in 
the infracted hemisphere we used unbiased stereology (Optical fractionator), the 
results are an estimate of the total number of cells. The results were analyzed 
using GraphPad Prism 5.0 for Mac. 1 way Analysis of Variance was follow by 
Bonferroni’s Multiple Comparison Test. p-value of <0.05 were considered 
statistically significant.
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Results 
We designed the experiment with 70 animals; 6 of them (1 animal per 
group), were excluded because the Doppler never showed a sharp decrease in 
blood flow (at least 60% decrease). We believe that either the intra-arterial tread 
or the Doppler were misplaced. 9 more animals died during the surgery from 
subarachnoid hemorrhage, bleeding from the arterial incision and other technical 
issues; this include 3 animals in the control group, 1 animal in the Isoflurane 
group, 2 animals in the Isoflurane plus caspase 3 inhbitor, 2 animals in the 
propofol plus caspase 3 inhibitor and 1 in the caspase 3 group. 12 animals died 
or were euthanized due to neurological dysfunction between the day of the 
surgery and day 14; this included 6 animals in the control group, 1 in the 
Isoflurane group, 2 rats in the propofol group, 1 in the propofol plus caspase 3 
inhibitor group and 2 in the caspase 3 inhibitor group. No replacement animals 
were added to the study.  
As previously described several physiological variables were considered. 
We evaluated rectal temperature, mean arterial pressure (MAP), heart rate (HR), 
hemoglobin saturation (Hg-Sat), and hematocrit. The results are shown in the 
table below. We did not find any statistically significant differences between the 
pre-operative values and the post-operative values. We also did not find 
statistically significant changes in the initial and final weight measured before the 
ischemic event and at day 14.  Physiological variables are shown on Table 4. 
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Table 4. Physiological Variables. Values are mean ± SD. MAP = Mean 
Arterial Blood Pressure, HR = Heart rate, T0 = Temperature, C3I = Caspase 
3 inhibitor, MCAO = Middle Cerebral  Artery Occlusion, BPM = Beats Per 
Minute, Hb = Hemoglobin. 
 Neurofunction index was calculated in the animals as shown in the next 
figure (Neurological Scores) (1).  Behavior measurements on postoperative day 4 
demonstrated a reduction of impairment in both groups receiving the caspase 
inhibitor ( p < 0.05). This trend is voided by day 14, when all animals approached 
baseline scores. The test used for this purpose was an eight point neurological 
score (from 0 to 7) the animals that score 0 were perfectly normal and the 
damage progress until a score of 7 when the animal is dead. This score only 
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measures motor behavior; it does not include the sensory system, memory or 
any other abilities.  
 
 
 
 
Figure 1. Neurological Performance. Behavior measurements on 
postoperative day 4 demonstrated a reduction of impairment in both 
groups receiving the caspase inhibitor.  This trend is voided by day 14, 
when all animals approached baseline scores. 
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 We used Stereology (Cavalieri Method) (17) to accurately measure infarct 
volume. To compensate for edema, we compared the ipsilateral infarcted area with 
the contra lateral hemisphere area. Significant differences in infarct volume were 
observed. The groups treated with anesthetics alone (Isoflurane and Propofol) 
showed no significant differences in infarct size compared to the control group. 
However, the addition of caspase 3 inhibitors to Isoflurane resulted in up to 50% 
reductions in infarct size 14 days after permanent focal cerebral ischemia ( p < 
0.05 ). See Figure 2. 
 
Figure 2. Relative infarct area to compensate for edema. The graph shows 
the quantification of the average volume of infarct size 14 days after 
permanent focal cerebral ischemia as determined by stereological analysis 
 of H&E histochemistry. C3I (Caspase 3 Inhibitor) 
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 Infarct volumes are shown in the figure, photomicrographs of brain sections 
were taken from MCAO rats in all groups. Total infarct volume including cortical 
and subcortical structures were measured.  The only group that showed a 
statistical significant difference was the group treated with Isoflurane plus the 
caspase 3 inhibitor ( p < 0.05 ). 
 
 
Figure 3. Microphotographs of the infarcts at day 14 after the injury. 
Isoflurane plus caspase 3 inhibitor reduce the infarct size in Sprague 
Dawley rats 14 days after stroke. C3I = Caspase 3 Inhibitor. 
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  Neither propofol nor isoflurane alone showed any statistically 
demonstrable benefit after 14 days. Interestingly, the combination of propofol 
plus the caspase inhibitor and the caspase inhibitor by itself did not show a 
demonstrable benefit. Thus, elevations in caspases that follow focal ischemia 
appear to contribute to the ischemic injury and are critical targets to reduce 
infarct size only in combination with isoflurane for this particular ischemic model.  
  The number of neurons that were positive for TUNEL two weeks after 
permanent occlusion of the middle cerebral artery plus common carotid artery 
occlusion, were not significantly different in the groups that were treated with 
propofol and Isoflurane alone compared to the control group. However, the 
number of positive TUNEL neurons were significantly lower in animals that 
received the caspase 3 inhibitor in comparison to the animals that did not.          
(p < 0.05 for the three groups). 
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Figure 4. Estimated total number of TUNEL positive cells in the stroke 
hemisphere. The number of TUNEL positive cells is lower in the animals 
that received the C3I ( Caspase 3 Inhibitor ).  
  These results were confirmed with the significant reduction in cleaved 
caspase 3 positive cells in the groups treated with the caspase 3 inhibitor 
compared to the control group and with the rats treated with anesthetics alone     
(p< 0.05 for the three groups). 
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Figure 5. Estimated total number of cleaved Caspase 3 positive cells in the 
stroked hemisphere. The number of cleaved caspase 3 positive cells is 
significantly lower in the animals treated with C3I ( Caspase 3 Inhibitor ). 
 
Discussion: 
The results suggest that the intraperitoneal injection of Z-DEVD-FMK, 
caspase 3 inhibitor in combination with isoflurane has a neuroprotective effect in 
a model of permanent cerebral ischemia two weeks after the initial injury. 
It is important to mention that the volume size of the Z-DEVD-FMK group is 
statistically significant when the statistical analysis is done using Anova followed 
by Bonferroni test but it disappeared when we used Fisher LSD as post-test. We 
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decided to publish only the Fisher LSD results because it is the most widely used 
test in ischemia research.  
At day four the neurological score only showed significance in the groups 
that received the combination, this is another reason to consider that the caspase 
3 inhibitor by it self does not have a neuroprotective effect in this model of 
permanent ischemia. The neurological findings were correlated with the 
histological findings, showing that the combination of Z-DEVD-FMK, caspase 3 
inhibitor and isoflurane is indeed neuroprotective. Isoflurane or propofol are not 
neuroprotective when administered alone in this model of permanent ischemia 
two weeks after the insult.  
Although apoptosis plays an important role after ischemia and blocking it 
seems to be the right answer; we have demonstrated that apoptosis is not the 
only answer in neuroprotection, it is also important to block the necrosis and 
anesthetics have demonstrated to be useful in this area (5). In previous studies, 
researchers have used intracerebral injections of caspase inhibitors (11,18), in 
this study we used intraperitoneal injections of a caspase 3 inhibitors, we believe 
that since the hematoencephalic barrier is broken after a stroke that facilitates 
the entrance of the caspase inhibitor. We measured the number of apoptotic cells 
in the infarcted hemisphere and we found a significant decrease in the TUNEL 
positive cells in all the groups that received the caspase inhibitor. We also 
counted the number of cleaved caspase 3 positive cells in the infarcted 
hemisphere to confirm the results found in the TUNEL analysis and the results 
were similar.  
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Since not all the groups that received the caspase inhibitor showed a 
significant decrease in infarct size we conclude that Isoflurane plays an important 
role as neuroprotective agent. We used a model of permanent cerebral ischemia, 
the presence of the surgical treat in the arterial side causes a continuous local 
reaction leading to apoptosis, and this is one of the factors that may explain the 
positive effect of caspase inhibitors in this model.  
In this study we corroborate that in a model of MCAO plus CCAO the 
addition of caspase inhibitors is necessary to achieve neuroprotection that 
anesthetics alone do not offer. The differences found with results reported by 
Sakai et al; (5) could be justified by the fact that we created permanent global 
ischemia since we permanently occluded the common carotid artery. Sakai 
reported persistent protection from Isoflurane with no need for the use of a 
caspase inhibitor and provided good evidence that the difference with Kawaguchi 
et al; (12) was due to the later using  an MCAO model  that integrated permanent 
carotid occlusion  and thus persistent hypoperfusion. On the other hand, Elsersy 
et al; (19) showed evidence of decline of the protective effect of Isoflurane over 
time; suggesting  that the protection between local and global ischemia is 
different. It seems clear now that volatile anesthetics have a neuroprotective 
action under specific conditions (mild to moderate severity) (20). 
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Abstract: 
 
Introduction:  
Maintenance of adequate blood flow to the brain is necessary in the 
course of general anesthesia in order to assure safe recovery and normal brain 
function after surgical intervention. Brief episodes of hypotension have been 
shown to cause acute brain damage in animal models. We used a rat 
hemorrhagic shock model to assess functional outcome and to measure the 
relative neuronal damage at 1, 4 and 14 days post-injury. 
Methods:  
250g to 350g Sprague-Dawley male rats were subjected to severe 
hypotension induced by withdrawal of arterial blood from the right femoral artery, 
while under Isoflurane anesthesia. The mean arterial blood pressure was 
maintained between 20-30 mm Hg for one minute per hour, for a total of 3 times 
per rat in a two hour period. Shed blood was immediately returned to venous 
circulation, returning systemic pressure to normal. The rats were separated into 4 
groups as follow: groups 1, 2 and 3 received 3 minutes of hypotension - 1 minute 
every hour - and were evaluated at 1, 4 and 14 days, respectively. An additional 
group of rats, group 4, received a sham operation. A neurological assessment 
including motor abilities, sensory system evaluation and retrograde memory was 
performed at 1, 4 and 14 days post-hypotensive insult. Brains were harvested 
and stained for Fluorojade C and Nissl at 1, 4 or 14 days. Stereology was used to 
analyze Fluorojade C and Nissl stained brain sections to quantitatively detect 
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neuronal damage after the hypotensive insult. Statistical analysis was performed 
using Graphpad Prism 5 with the Bonferroni test at a 95% confidence interval, 
after ANOVA and for passive avoidance evaluation, Mixed Effect Model was 
used. 
Results:  
We used a rat hemorrhagic shock model to assess behavior and 
functional outcome and to quantify the relative neuronal damage at 1, 4 and 14 
days post-hypotension. Significant differences in cell injury were seen between 
control rats and rats that received 3 minutes of hypotension solely at one day 
after the insult represented by numerous Fluorojade positive cell in the 
hippocampus quantified by using stereology (optical dissector).  Also, a 
significant decrease in the number hippocampal cells was seen at day 14. No 
changes in frontal cortical cells were evident at any time.   
Discussion:  
Our observations suggest that in this hemorrhagic model in Sprague-
Dawley rats, even brief periods of hypotension result in cell damage. We did not 
find any significant changes in behavior in this study, 
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Introduction: 
 Maintenance of adequate blood flow to the brain is necessary in the course 
of general anesthesia for all patients in order to assure safe recovery and normal 
brain function after surgical intervention (1,2). Predictable models of neuronal 
loss after progressive low blood pressure insults have been developed.  
Yamauchi et al; have described selective progressive damage to regions of the 
brain after 2, or 3 minute episodes of profound hypotension (low blood pressure, 
25 mmHg) after one week of recovery (3,4). These changes were carefully 
attributed to neuronal necrosis, or accidental cell death, measured one week 
after all rats survived the hypotensive challenge. However, this study did not 
measure functional behavior after recovery from hypotension.  
 Cognitive dysfunction has been linked with hypotension (5,6), especially in 
elderly patients (7-9). Several studies have studied the relation between 
hypotension during surgery and neurological performance after surgery but so far 
a clear link has not been found (10). The largest study that evaluated this matter 
was “The International Study of Postoperative Cognitive Dysfunction” but no 
association between surgical blood pressure and postoperative cognitive function 
was found (11). In contrast, other researchers have found a link between 
postoperative cognitive function and blood pressure during surgery(12,13).  
 With this in mind we designed an animal study that was able to show a 
clear link between blood pressure during surgery and long-term functional 
alterations. The investigation of short bouts of hypotension with lack of brain 
activity will provide evidence of the amount of brain damage caused at an 
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extended two week period. It is likely that the damage can be more effectively 
quantified with combined behavioral and tissue analysis at extended time points. 
A secondary objective of this study is to characterize an animal model of 
hypotension that would produce cerebral ischemia useful for testing of anesthetic 
protection. 
Materials and Methods. 
Regulations:  
The present study was presented, evaluated and approved by the division 
of Comparative Medicine at the University of South Florida (USF). The 
experiments were done in following the guidelines of the IACUC of the University 
of South Florida’s College of Medicine.  
 
 
Table 1. Study Design. The rats were separated into four groups as follows: 
groups 1, 2 and 3 received 3 minutes of hypotension - 1 minute every hour - 
and were evaluated at 1, 4 and 14 days, respectively.  An additional group 
of rats, group 4, received a sham operation. 
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Table 2. Time course. Neurological assessment including motor abilities, 
sensory system and retrograde memory were evaluated at 1, 4 and 14 days 
post-hypotensive insult. Brains were harvested at 1, 4 or 14 days. 
 
Animals:  
              Male Sprague Dawley rats from Harlan Laboratories (Indianapolis, IN), 
with ages between 60 to 90 days and weights between  250 to 350 grams were 
used for this experiment. Upon arrival to the USF College of Medicine Vivarium, 
the rats were housed in a climate controlled room in plastic cages in groups of 
two with free access to water and food and were left in quarantine for at least a 
week before the experiment took place. 
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Groups:  
The animals were divided in 4 groups:  
1. Control group; these animals received no hypotension. 
2. These animals received 3 minutes of hypotension and were euthanized 24 
hours after the surgery. 
3. These animals received 3 minutes of hypotension and were euthanized 4 days 
after the surgery. 
4. These animals received 3 minutes of hypotension and were euthanized 14 
days after the surgery.
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Neurological Assessment: 
           We used a forty-eight point neurological score to evaluate the animals 
(14). The test was done at 2 different time points. The first evaluation was the 
day before the surgery, this test was done to assure that neurologically the rats 
were intact; having an animal with any kind of neurological deficit would prevent 
the animal to be part of the study. No animals were withdrawn from the study 
under those criteria. The second evaluation was before tissue collection. The 
neurological scale is shown in Table 3. 
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Table 3. Fourty eight points neurological scale. This scale has been used in 
previous papers and includes general status and motor and sensory 
abilities (14). 
 
We wanted to evaluate memory function; to achieve this we used the 
passive avoidance paradigm. Habituation is the first step, the animal was placed 
TEST 0 1 2 3 4
Spontaneous activity 
(5min)
Normal Calm, quiet, 
explores slowly
Somnolent; 
minimal 
exploration
Stuporous; some 
movements in 
place
No 
spontaneous 
movement
Body symetry Normal Slight asymmetry Moderate 
asymmetry
Prominent 
asymmetry
Extreme 
asymmetry
Gait (open bench top) Normal Stiff inflexible Limping Trembling, 
drifting, falling
Does not walk
Front limb symetry Normal Light asymmetry Marked 
asymmetry
Prominent 
asymmetry
No body/limp 
movement
Circling/bench top Not present Predominantly one 
sided turns
Circles to one side Circles 
constantly to one 
side
Pivoting, 
swaying or no 
movement
Circling/holding tail Not present Tendency to turn to 
one side
Circles to one side Pivots to one 
side sluggishly
Does not 
advance
Hind limb placement Normal Slow placement No placement - -
Vertical screen climbing Normal Climbs with strains; 
limb weakness 
present
Holds onto slope; 
does not slip or 
climb
Slide down slope Slides 
immediately; no 
effort to prevent 
fall
Beam walking Walks to the 
end of the 
beam
Walks to the middle 
of the beam
No walking, stays 
more than 10 s
Unsuccessful 
effort to prevent 
fall
Falls 
immediately
Fore limb touch (needle) Normal Withdraws slowly No withdrawal - -
Hind limb touch (needle) Normal Withdraws slowly No withdrawal - -
Trunk touch (needle) Symmetric Light asymmetry Prominent 
asymmetry
Absent 
ipsilateral and 
diminished 
contralateral 
response
Response 
absent 
bilaterally
Vibrassae touch Symmetric Light asymmetry Prominent 
asymmetry
Absent 
ipsilateral and 
diminished 
contralateral 
response 
Response 
absent 
bilaterally
Face touch (needle) Normal Withdraws slowly No withdrawal - -
Complex motor
General status
Simple motor
Sensory
POINTS
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on a platform in a plexiglass box and we measured the time they remained on 
the platform before they step down of it. Next day is training day: we placed the 
animal on the platform and once the animal had positioned the four limbs down 
the platform it received an electric shock (0.5mA) for three seconds. The animal 
learned that the safe place to be was the platform.  
In this case we were testing retrograde memories so the animals were 
trained before the surgery. On the day before tissue collection; the animal was 
placed in the platform and we measured the time it took to step down the 
platform up to a maximum of 5 minutes (300 seconds). Latencies greater than 
300 seconds were assigned this value. Finally, on the euthanasia day we 
measured the time the animal stayed on the platform up to 5 minutes.  
Anesthesia: 
After the weight was recorded, the animal was anesthetized in an 
induction chamber with 5% Isoflurane in 100% Oxygen. After the rat was fully 
anesthetized we changed the animal from the induction chamber to a mask with 
1 to 2% Isoflurane in 100% oxygen. The rats were continuously anesthetized 
during the three episodes of hypotension. 
Surgery: 
After shaving the neck, the area was cleaned with iodine and a medial 
linear incision was made. Plastic catheters were inserted in the jugular vein and 
both carotid arteries (bilateral). The arterial lines were used for blood pressure 
quantification and blood aspiration; the venous line was used for blood 
reinfusion. The blood was rapidly aspirated until the mean arterial pressure 
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(MAP) reached a point below 20; if the animal did not reach a MAP below 20 at 
any of the 3 episodes, it was excluded from the experiment.  
When MAP was below 20, the chronometer was set for 60 seconds. 
Between 8 cc to 15 cc of blood were taken to reach MAP of 20 or less. After the 
minute, the blood was reinfused using the venous catheter. During the procedure 
the animals were placed on a heated pad to prevent hypothermia. At the end of 
the third hypotensive episode the catheters were removed and skin was closed 
with a skin stapler. The rats recovered in a fresh cage. 
Physiological parameters: 
The following variables were measured: Weight, temperature measured 
with a rectal thermometer (a heated pad was used to maintain body temperature 
during the procedure); a pulse oximeter was used to measure hemoglobin 
saturation (Hb Sat); heart rate (HR) and blood pressure (BP) were obtained 
directly from an arterial catheter placed in the carotid artery (SurgiVet Advisor 
Monitor. Model number 92V303100 was used for Hb Sat, HR and BP).  Readings 
were made before and after each ischemic event. Weight was measured right 
before the surgery and at day 14. 
Brain Extraction and Sectioning 
The animals were euthanatized with an overdose of CO2; immediately 
after the animal was perfused with normal saline solution 0.9% followed by 4% 
paraformaldehyde. The brains were harvested, stored in plastic tubes with 4% 
paraformaldehyde for 24 hours, and then changed to 10%, 20% and 30% 
sucrose every 24 hours. Brains were then sectioned at 40µm with cryostat HM 
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550 from MICROM International, the chamber temperature was turned down to 
minus 22°C. A series of 5 coronal sections spaced approximately 960 microns 
apart were stained. Fluorojade C and Nissl were used for histological analysis. 
The sections were mounted for histopathology analysis and remaining sections 
were stored in PBS plus Azide. 
Fluoro Jade C: 
Fluoro Jade C stain is commonly used in ischemia research to label 
degenerating neurons regardless of the insult. Fluoro Jade C analysis was used 
to quantify the number of degenerating cells in cortex and CA1 area of the 
hippocampus; the method used is described in detail (15). The sections were 
mounted on slides and air-dryed overnight. Then, dipped in absolute ethyl 
alcohol 3 times, and 1 minute in 70% ethyl alcohol; washed in running tap water 
1 minute. Stained with potassium permanganate to oxidize tissue for 15 min 
while shaking gently. 120 mg of potassium permanganate (KMnO4) 0.06% was 
diluted in 200 mL of PBS. At this point the slides were protected from light. 
Staining with Fluoro Jade C 0.001% for 30 minutes was follow by 3 changes of 
water for 1 minute and air dry overnight. The next day under the fume hood, clear 
in xylene for 2 minutes, 3 times. Coverslipwith DPX directly from xylene. Fluoro-
Jade stock was made with 0.01% Fluoro Jade C in water (dilute 2 mg/ 20 ml). 
The working solution was made with 0.001% Fluoro-Jade C in 0.1% acetic acid. 
Dilute 20 ml stock with 180 mL of water plus 200 uL of acetic acid.  
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Nissl: 
Nissl is a classic stain used for detection of Nissl bodies in the cytoplasm 
of cells, which will be stained purple-blue. Sections were mounted and let air dry 
on a slide warmer overnight.  Next day they were dehydrated through 100% and 
95 % alcohol to distilled water. After that were stained in 0.1% cresyl violet 
solution for 5 minutes and then rinsed with distilled water.  
Following they were immersed in 95% ethyl alcohol for 30 minutes and posterior 
dehydrated in 100% alcohol 2 times for 5 minutes. Under the fume hood they 
were cleared in xylene for 2 minutes, 3 times and then immediately coverslip with 
DPX . 
Statistical Analysis: 
The data is presented as Mean ± SE. Counting of Fluoro Jade C positive 
cells and Nissl cells was done using unbiased stereology (Optical fractionator) as 
described in by Mouton (16). For this purpose the Stereologer from Stereology 
Resource Center, Chester, Maryland was used. The results are an estimate of 
the total number of cells. Neurological score data were also evaluated. One way 
Analysis of Variance was follow by Bonferroni’s Multiple Comparison test. The 
results were analyzed using GraphPad Prism 5.0 for Mac. Passive avoidance 
was evaluated using Mixed Effect Model. p-value of <0.05 were considered 
statistically significant.
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Results 
We designed the experiment with 40 animals, 7 of them died during 
surgery. 3 from the group that undergo euthanize at day 1, 2 animals belong to 
the group that was euthanized at day 4 and 2 more from the group that was 
euthanized at day 14. Necropsies showed that pulmonary embolism and 
technical complications were the main culprits. 5 more animals died after 
surgery; bleeding from the arterial incision and neurological deficits were the 
cause; this included 2 animals in the group that was euthanized at day 4 and 3 
animals in the group that was euthanized at day 14. Dead animals were not 
replaced (See Table 4).  
Physiological variables were considered. The results are shown in the 
next figure. The mean arterial pressure combining all the groups before the first 
insult was 100.3 + 42, 94.3 + 38 before the second insult and 102 + 40 before the 
last insult. After the insult the mean arterial pressure was 87.7 + 56.2, 94.5 + 
57.2 and 92.7 + 43.2 respectively. During the hypotension period, the blood was 
withdrawn until the MAP reach 20 or less. 
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Table 4. Physiological variables. Values are mean ± SD. MAP = Mean 
Arterial Pressure, HR = Heart rate, To = Temperature, BPM = Bits Per 
Minute, Hb = Hemoglobin, F°= Fahrenheit. No significant differences were 
found. 
 
We did not find any statistically significant differences between the pre-
operative values and the post-operative values. We also compared the weight 
before the ischemic event and at day 14, and did not find any statistically 
significant change.  
Control 
(n=10) 
Euthanize day 1 
 (n=7) 
Euthanize day 4 
(n=6) 
Euthanize day 14 
(n=5) 
Initial Weight (g) 333 + 18 352 ± 11 334 ± 12 344 ± 22 
Final Weight (g) 370 + 20 349 ± 13 361 ± 29 380 ± 39 
Initial T°  (F°) 94.8 ± 2.2 93.02 ± 2.6 92.58 ± 4.3 
Final T°  (F°) 89.6 ± 7.5 91.88 ± 2.6 88.8 ± 3.1 
First MAP 19 ± 2 20 ± 2  19 ± 2 
Second MAP 19 ± 1 19 ± 1  20 ± 1 
Third MAP 20 ± 2 18 ± 1  19 ± 1 
Initial HR  (bpm) 254 ± 43 271 ± 50 248 ± 61 
Final HR (bpm) 267 ± 49 233 ± 59 250 ± 54 
Initial Hb. Saturation 97 ± 2 94 ± 6 95 ± 4 
Final Hb. Saturation 95 ± 5 94 ± 4 98 ± 7 
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Neurological performance was evaluated in all animals as shown in the 
next figure (Neurological Scores). Behavior measurements on postoperative day 
1, 4 and 14 were compared with control; at day one there were positive findings 
(palpebral ptosis). These findings were not present at day 4 or 14. Although there 
was neurological impairment 24 hours after the injury, statistically, these changes 
were not significant (p > 0.05). It is important to mention that some animals also 
showed some degree of paralysis right after the surgery but by the time of the 
neurological evaluation it was no longer present.  
 
Figure 1. Neurological Score. The figure show no significant changes in the 
neurological score. The only change found at 24 hours was palpebral 
ptosis in some animals, this finding was not present at day 4 or 14.  
  Passive avoidance as described by Saporta (17), was used to tested the 
ability to recall old memories. During the habituation and training, animals 
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learned to stay on the platform to avoid an electric shock. We confirmed learning 
by measuring the time the rat stayed on the platform before hypotension and 
later we retested the animals after hypotension.  
  We did not find any memory impairment in the animals after the surgery in 
comparison with the control animals. 
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Figure 2. Passive avoidance. None of the animals have any memory deficit 
after the procedure at any of the check points. 
 Stereology was used to estimate the total number of positive Fluoro Jade 
C cells in the frontal cortex and CA1 area of the hippocampus. No significant 
differences in cell injury represented by numerous fluoro jade positive cortical 
cells were seen between control rats and rats that received 3 minutes of 
hypotension (p > 0.05)  
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 Effect of 3 minutes of hypotension in frontal cortex.  
 
Figure 3. Effect of 3 minutes of hypotension in frontal cortex. Estimated 
total number of Fluoro-Jade C positive cells in animals subject to 3 min of 
hypotension. 
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Figure 4. Pictures from frontal cortex. Fluoro jade C positive cells in 
cortical areas in animals subject to 3 minutes of hypotension. 
 On the other hand significant differences in cell injury were seen between 
control rats and rats that received 3 minutes of hypotension solely at one day 
after the insult represented by numerous fluoro-jade C positive cells in the CA1 
area of the hippocampus (p < 0.05). See Figure 5 and 6. 
 
Figure 5. Effect of 3 minutes of hypotension in the CA1 area. Group 1 = 
Stereology cell count in CA1 region, euthanize at day 1; Group 4 = 
Stereology cell count in CA1 region, euthanize at day 4; Group 14 = 
Stereology cell count in CA1 region, euthanize at day 14. There is a 
statistically significant difference in between control and group 1. 
. 
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Figure 6. Pictures from CA1 area of the hippocampus. One day after injury 
there are more fluoro jade positive cells than in the rest of the groups 
 We also counted Nissl cells in the frontal cortex and CA1 area of the 
hippocampus and we found that the cortex was not statistically affected by the 3 
episodes of 1 minute of hypotension at any of the 3 time points. In contrast, the 
CA1 area of the hippocampus suffered a continuous decrease in the number of 
cells  statistically significant only at day 14 after the 3 non-consecutives minutes 
of profound hypotension. 
Results of the Nissl staining confirmed the findings of fluoro jade c; the 
number of cells did not change in the frontal cortex but in the CA1 hippocampal 
area there was a significant detriment in the number of cells evidenced two 
weeks after the insult. The results from the Nissl cortical counting in the CA1 
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area of the hippocampus are shown in figure 10 and 11 respectively. See Figures 
7 and 8. 
 
 
Figure7. Estimated total number of Nissl positive cells in frontal cortex. 
There are no statistically significant differences between control and the 
animals euthanized at day 1, day 4 and day 14. 
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Figure 8. Estimated total number of Nissl cells two weeks after the insult in 
the CA1 area of the hippocampus.  At day 14 after the insult there is a 
statistically significant difference in comparison with control. 
The results in the CA1 area are congruent with the results found in the 
Fluoro Jade C staining; Fluoro Jade C shows an increase in the number of cells 
that suffered some degree of damage and in this case the day after the surgery 
there was a significant increase of damaged cells. At day 14, as shown with the 
Nissl stain, the cells that were injured at day 1 are gone and the number of 
normal cells in the CA1 area is significantly lower.  
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Discussion: 
The present observations evidenced that repeated hypotensive episodes 
lead to hippocampal damage, which may have clinical implications. Patients with 
hemodynamic TIAs, cerebral arteriosclerotic disease, or orthostatic hypotension 
may experience repeated nonfatal circulatory deficiencies. Our results suggest 
that in this rat hemorrhagic model, brief periods of hypotension result in neuronal 
damage or distress in the hippocampal CA1 region one day after insult. By day 
14, surviving cells are significantly reduced in the hippocampus. We did not find 
any significant changes in cortical cells.  
We evaluated the changes in weight in all the groups and there was not a 
significant change; we believe that although the animals showed some 
histological changes in the CA1 area of the hippocampus the damage is not 
enough to induce weight changes.  
Hypothermia has also shown to reduce ischemic damage(18), to prevent a 
hypothermic state in our animals a heated pad was placed underneath the rat 
preventing the presence of variables of confusion. There were not significant 
changes in the initial and final temperature. The mean initial temperature was 
93.5 + 3 and the final was 90 + 4.4. 
Between 8 cc to 12 cc of blood were taken each time to achieve a mean 
arterial blood pressure below 20. The mean arterial blood pressure for all the 
groups at the beginning of the hypotensive period was 19.2 + 1.1. Yamauchi 
(3,4) found histopathological changes after one week; in the hippocampus with a 
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MAP of 25 with 2 or 3 minutes of hypotension.  In our hands these changes 
continue to be present two week after the insult. 
The forty-eight points neurological scale did not show any statistically 
significant changes Interestingly we found temporal paralysis in the upper body 
that lasted only few hours; by the time of the neurological evaluation the paralysis 
was gone and could not be recorded as a positive finding. A common finding 
after 24 hours of recovery was palpebral ptosis but statistically this finding was 
not significant; in all the cases where palpebral ptosis was found, recovery was 
complete by day 4. In humans the dissection of the Internal carotid artery, 
typically manifests as an oculo-sympathetic palsy (myosis and palpebral 
ptosis)(19), we placed the catheters in the common carotid artery but since the 
surgical area is small, it is possible that we had manipulated the internal carotid 
artery leading to this finding. 
Passive avoidance paradigm has been used for memory evaluation; 
Bekker et al. have demonstrated using this paradigm that hypotension can cause 
disruption in consolidation of long term memory. In the present study we did not 
find any memory alterations (20). We hypothesize that this difference is due to 
either the type of hypotension; since they used nitroglycerine and we withdrawn 
the blood. The other important difference is the time of hypotension; Bekker 
caused the hypotension early after the learning; in fact the latest injection was 
given 3 hours after the training. In our study we trained the animals 24 hours 
before the surgery and tested 24 hours after the surgery giving them enough time 
to consolidate their memories. This study demonstrated that although there is 
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damage in the hippocampus after 3 separate periods of profound hypotension, 
memories that are already consolidated were not affected.  
Fluoro Jade C stain is a fluorescein derived used to label degenerating 
neurons. We used this staining to evaluate brains on 1, 4 and 14 days after 
hypotension. In a pilot study we evaluated the fluoro jade c stained brains; the 
samples were viewed with a fully automated, upright Zeiss Axio- ImagerZ.1 
microscope (Carl Zeiss Inc., Germany) with a 20x /0.5NA objective and a FITC 
filter cubes. Images were produced using the AxioCam MRm CCD camera and 
Axiovision version 4.6 software suite (Carl Zeiss Inc., Germany). The resulting 
images were analyzed for number and intensity of degenerative neurons using 
Image Pro Plus 6.2 (Media Cybernetics Inc., Silver Springs, Maryland). We used 
the confocal microscope to have a better visualization and also to take pictures. 
Samples were viewed with a Leica DMI6000 inverted microscope, TCS SP5 
confocal scanner, and a 40X/1.30NA Plan Apochromat oil immersion objective 
(Leica Microsystems, Germany). An argon laser line was applied to excite the 
samples and tunable filters were used to minimize background fluorescence. 
Image were captured with photomultiplier detectors and prepared with the LAS 
AF software version 1.6.0 build 1016 (Leica Microsystems, Germany). At this 
point we found a significant difference in the in the number of fluoro jade c 
positive cells in the frontal cortex at day 1(21), however this significant difference 
was not evident when stereology was used. Results found in Fluoro jade c cells 
at day one in the CA1 hippocampal area were significant with the two methods. 
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We concluded that one day after repetitive periods of hypotension there is brain 
damage that can persist after 2 weeks. 
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Abstract: 
Introduction:  
Previous studies in our lab have demonstrated that short periods of 
hypotension can cause histological changes in the hippocampal CA1 area, while 
behavior remains unchanged (1). We believe that an even stronger insult may 
also cause behavioral changes. We used a rat hemorrhagic shock model plus 
temporary hypoxia to assess functional outcome at different time points post-
injury. 
 
Methods:  
Sprague-Dawley rats were subjected to brief, severe hypotension induced 
by withdrawal of arterial blood from the right femoral artery. Mean arterial blood 
pressure was reduced to 20 to 30 mm Hg for three consecutive minutes, while 
the animal was breathing 12% O2 in N2. Mean Hb saturation was maintained at 
74.2%. After the 3 minutes shed blood was immediately returned to venous 
circulation, returning systemic pressure to normal. At the end of the hypotensive 
period the animals were returned to breathing air. Animals were evaluated at 
different time points before their brains were harvested for quantitative histology. 
Group 1: Control, normal animals with no injury.  Neurological evaluation at day 
0, 1, 4 and 14, passive avoidance at day 3, 4, 7 and 14, euthanized at day 14. 
Group 2 received hypotension plus hypoxia: Neurological evaluation before the 
surgery and at day 1, euthanized at day 1; Group 3 received hypotension plus 
hypoxia: Neurological evaluation before the surgery and at day 4, euthanized at 
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day 4; and Group 4 received hypotension plus hypoxia:  neurological evaluation 
at day 0, 1, 4 and 14, passive avoidance at day 3, 4, 7 and 14, euthanized at day 
14. Group 5 received hypotension plus hypoxia and was treated with isoflurane 
per 90 minutes after the insult:  neurological evaluation at day 0, 1, 4 and 14, 
passive avoidance at day 3, 4, 7 and 14, euthanized at day 14. 
We used a 48 point neurological evaluation scale, in which the higher the 
number the worse the deficit (2). Histopatologycal analysis  with NeuN and Nissl 
was performed. Statistical evaluation with ANOVA followed by Bonferroni test for 
NeuN and Nissl results; for neurological evaluation we used Dunnett’s multiple 
comparison test after ANOVA and for passive avoidance a Mixed Effect Model 
was used. Significance was defined as p < 0.05. 
 
Results:  
Neurological assessment showed that hypotension plus hypoxia resulted 
only in little abnormalities, but no statistically significant changes were found. In 
the passive avoidance test we found that new memories were still created after 
the injuries but animals with no hypotension/hypoxia had a better performance in 
comparison with the hypotension/hypoxia. The use of isoflurane 90 minutes after 
the insult showed to protect the animals from memory alterations. No 
histopatological changes were found in any of the groups. 
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Discussion:  
This observation suggests that in this model of hypotension plus hypoxia 
there is mild cerebral damage that is reflected by memory changes and this 
deficit is maintained two weeks after the insult. Exposure to isoflurane after the 
insult can prevent the onset of memory deficits. 
 92 
Introduction: 
 Recent publications have shown that hypotension during surgery can 
produce a range of effects from post operative memory deficits (3) to an increase 
in mortality during the next year after surgery; specially in elderly patients (4). 
Permanent, stable and adequate blood flow to the brain is necessary during 
general anesthesia in order to assure safe recovery and normal brain function 
after a surgical intervention(5,6).  
 Some researchers have demonstrated that hypotension can have 
deleterious effects in brain histology. Yamauchi et al; described progressive 
damage to several regions of the brain after three separated 1-minute episodes 
of hypotension (Mean Arterial Pressure 25 mmHg) after seven days of recovery 
in rats (7,8). Although Post Operative Cognitive Dysfunction (POCD) does not 
have a clear etiology, some physicians believe Intra Operative Hypotension 
(IOH) may be the culprit (9,10). Schutz et al; found that a 30 minute period of 
hypotension does not have any effect in structural and motor deficits but has 
some effects in recovering cognition (11). Hypertensive patients seem to be more 
sensitive to IOH, Yocum et al; has found a clear relation between IOH in 
hypertensive patients and decline in cognitive function (12). Patients with 
advanced age seem to be more vulnerable to POCD after IOH (13-15) but not all 
the studies have shown a clear relation between IOH and POCD (16,17).  
In our laboratory, using a rat model of hypotension, we have found a clear 
relation between IOH and histological changes in the hippocampus but not the 
cortex and memory was not affected (1). 
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 Animal models of hypotension and hypotension plus hypoxia are necessary 
to study the effect of these variables and their effects in the central nervous 
system. In this study we evaluated the effect of a short period of profound 
hypotension plus hypoxia. Histology and behavioral testing was used in order to 
clearly understand the relation between these variables. 
Materials and Methods. 
Regulations:  
The present study was presented, evaluated and approved by the division 
of Comparative Medicine at the University of South Florida (USF). The 
experiments were done in following the guidelines of the IACUC of the University 
of South Florida’s College of Medicine.  
 
 
Table 1. Study design. The rats were separated into five groups as follows; 
group 1 was the control (no injury), the other 4 groups received 3 
consecutives minutes of hypotension plus hypoxia and were euthanized at 
day 1, 4 or 14; the last group received treatment with isoflurane per 90 
minutes. 
 
Five groups were used in this study; the first 4 groups shown were design 
to characterize the damage caused by hypotension plus hypoxia and the 
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isoflurane group was added to determine if the expected damage could be 
reversed with this anesthetic. 
 
 
Table 2. Time course. Neurological evaluation and memory test were used 
to evaluate the damage caused by hypotension plus hypoxia. 
 
The creation of new memories after the insult were evaluated using the 
passive avoidance paradigm as described by Saporta (18). A fourty eight point 
scale was used for neurological assessment at different time points in a two 
week period (2).   
Animals:  
Male Sprague Dawley rats from Harlan Laboratories (Indianapolis, IN), 
with ages between 60 to 90 days and weights between 250 to 350 grams were 
used for this experiment. Upon arrival to the USF College of Medicine Vivarium, 
the rats were housed in a climate controlled room in plastic cages in groups of 
two with free access to water and food and were left in quarantine for at least a 
week before the experiment took place. 
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Groups:  
The animals were divided in 5 groups:  
1. Control group, these animals received no hypotension.  
2. These animals received 3 minutes of hypotension plus hypoxia and were 
euthanized 24 hours after the surgery.  
3. These animals received 3 minutes of hypotension plus hypoxia and were 
euthanized 4 days after the surgery.  
4. These animals received 3 minutes of hypotension plus hypoxia and were 
euthanized 14 days after the surgery.  
5. These animals received 3 minutes of hypotension plus hypoxia, they also 
received treatment with isoflurane per 90 minutes after the insult and were 
euthanized 14 days after the surgery. 
Neurological Assessment:  
Neurological evaluation was performed twice in every animal. The first 
evaluation was the day before the surgery, this test was done to assure that 
neurologically the rats were intact; having an animal with any kind of neurological 
deficit would prevent it to be part of the study. No animals were withdrawn from 
the study for this reason. The second one was done before tissue collection. We 
used a forty-eight point neurological score to evaluate the animals. This scale 
was taken Yokoo et al, it is the result of combining elements of several systems; 
0 points indicate normal function, a total of 48 deficit point is possible (2). See 
Table 3.
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Table 3. Fourty-eight points neurological score. This scale includes general 
conditions, motor and sensory abilities giving a complete assessment of 
the neurological status of the animal.  
 
TEST 0 1 2 3 4
Spontaneous activity 
(5min)
Normal Calm, quiet, 
explores slowly
Somnolent; 
minimal 
exploration
Stuporous; some 
movements in 
place
No 
spontaneous 
movement
Body symetry Normal Slight asymmetry Moderate 
asymmetry
Prominent 
asymmetry
Extreme 
asymmetry
Gait (open bench top) Normal Stiff inflexible Limping Trembling, 
drifting, falling
Does not walk
Front limb symetry Normal Light asymmetry Marked 
asymmetry
Prominent 
asymmetry
No body/limp 
movement
Circling/bench top Not present Predominantly one 
sided turns
Circles to one side Circles 
constantly to one 
side
Pivoting, 
swaying or no 
movement
Circling/holding tail Not present Tendency to turn to 
one side
Circles to one side Pivots to one 
side sluggishly
Does not 
advance
Hind limb placement Normal Slow placement No placement - -
Vertical screen climbing Normal Climbs with strains; 
limb weakness 
present
Holds onto slope; 
does not slip or 
climb
Slide down slope Slides 
immediately; no 
effort to prevent 
fall
Beam walking Walks to the 
end of the 
beam
Walks to the middle 
of the beam
No walking, stays 
more than 10 s
Unsuccessful 
effort to prevent 
fall
Falls 
immediately
Fore limb touch (needle) Normal Withdraws slowly No withdrawal - -
Hind limb touch (needle) Normal Withdraws slowly No withdrawal - -
Trunk touch (needle) Symmetric Light asymmetry Prominent 
asymmetry
Absent 
ipsilateral and 
diminished 
contralateral 
response
Response 
absent 
bilaterally
Vibrassae touch Symmetric Light asymmetry Prominent 
asymmetry
Absent 
ipsilateral and 
diminished 
contralateral 
response 
Response 
absent 
bilaterally
Face touch (needle) Normal Withdraws slowly No withdrawal - -
Complex motor
General status
Simple motor
Sensory
POINTS
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Passive Avoidance: 
Memory was assessed using the passive avoidance paradigm (PA); 
habituation, training and testing were done after the hypotensive/hypoxic insult. 
Habituation occurred 24 hours after surgery: during habituation the animal was 
placed in a plexiglass box, the floor of the cage is an exposed metallic grid that 
can be manually electrified; on habituation day the animal is placed on a platform 
that prevent the animal from touching the grid and animals tend to spontaneously 
step down the platform and the latency is recorded. On the next day the grid is 
electrified with 0.5mA and again we measured the time they remained in the 
platform before they step down of it; once the animal have placed the four limbs 
down the platform, the animal received an electric shock (0.5mA) for three 
seconds. If memory process is intact the animal learns that the safe place to be 
is the platform. A day 3, 4, 7 and 14 we placed the animals on the platform and 
measured the time the animal took to step down of it, with a maximum of 5 
minutes (300 seconds). Latencies greater than 300 seconds were assigned this 
value. Finally on tissue collection day we took the time the animal remained on 
the platform up to 5 minutes. P.A. was only measured in the control group and 
the group euthanized at day 14 (18). 
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Anesthesia: 
After the weight was recorded, the animal was anesthetized in an 
induction chamber with 5% isoflurane in 100% oxygen. After the rat was fully 
anesthetized we changed the animal from the induction chamber to a mask with 
1 to 2% isoflurane in 100% oxygen. Animals remained anesthetized at all times. 
Animals in the isoflurane group received 1% isoflurane in 100% oxygen by mask 
for 90 minutes after the insult. 
Surgery: 
After shaving the neck, the area was cleaned with iodine and a medial 
linear incision was made. Plastic catheters were inserted in the jugular vein and 
both carotid arteries (bilateral). Arterial lines were used for blood pressure and 
blood suction; the venous line was used for blood reinfusion. Blood was 
aspirated until the mean arterial pressure (MAP) reached a point below 30. 
Hypoxia was induced with a mixture of 12% oxygen and 88% nitrogen, the 
animal breathed the mixture for 5 minutes before the hypotensive period and 
during the hypotensive period. As soon as MAP was below 30, the chronometer 
was set for 180 seconds. Between 8 cc to 15 cc of blood were taken to reach the 
MAP of 30 or less. After the hypotensive episode, the blood was reinfused using 
the venous catheter, and the hypoxic mixture was stopped and 100% Oxygen 
was given to the animal until the end of the surgery. The catheters were removed 
and the wound closed with a skin stapler. During the procedure the animals were 
placed on a heated pad to prevent hypothermia. Recovery from procedure was in 
a fresh cage. 
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Physiological parameters: 
Physiological parameters were measured to assure that the results we 
obtained due to the insult and could not related to alterations in physiologic 
changes. The variables we measured were: Weight, temperature taken with a 
rectal thermometer (a heated pad was used to maintain body temperature during 
the procedure), hemoglobin saturation with a pulse-oximeter (Hb Sat), finally 
heart rate (HR) and blood pressure (BP) were taken directly (SurgiVet Advisor 
Monitor. Model number 92V303100 was used for Hb Sat, HR and BP). Readings 
were taken before, during and after the ischemic event. Weight was measured 
before the surgery and at day 14. 
Brain Extraction and Sectioning 
The animals were euthanatized with an overdose of CO2, immediately 
after, the animal was perfused with normal saline solution 0.9% followed by 4% 
paraformaldehyde. The brains were harvested, stored in plastic tubes with 4% 
paraformaldehyde for 24 hours, and then changed to 10%, 20% and 30% 
sucrose every 24 hours. Brains were then sectioned at 40µm with cryostat HM 
550 from MICROM International, the chamber temperature was turned down to 
minus 22°C. A series of 5 sections spaced approximately 960 microns apart were 
stained. NeuN and Nissl stains were used for histological analysis. Sections were 
mounted for histopathology analysis and the remaining sections were stored in 
PBS plus Azide. 
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NeuN: 
NeuN (Neuronal Nuclei) is used to label alive neurons. Immunoreactivity is 
observed after mitosis. NeuN is primarily localized in the neuronal nuclei with 
lighter staining in the cytoplasm. The staining was done following the instructions 
from the manufacturer (Chemicon).  
Nissl: 
Nissl is used for detection of Nissl bodies in the cytoplasm of Cells. The 
Nissl body stain purple-blue. We used this staining to count the number of cells in 
the Hippocampus.  
Statistical Analysis: 
Data is presented as Mean ± SE. To count the number of NeuN positive 
cells and Nissl cells in we used unbiased stereology (Optical fractionator) as 
described in other publications (19-21). For this purpose the Stereologer from 
Stereology Resource Center, Chester, Maryland was used. The results are an 
estimate of the total number of cells. Neurological score and passive avoidance 
data were also evaluated. The results were analyzed using GraphPad Prism 5.0 
for Mac. One way Analysis of Variance was used followed by Bonferroni’s 
Multiple Comparison Test for NeuN and Nissl. For neurological evaluation we 
used Dunnett’s multiple comparison test after ANOVA. Passive avoidance was 
analyzed using the Mixed Effect Model to study the general differences between 
groups during the two week period; for specific time points we used One way 
Analysis of Variance followed by Bonferroni’s Multiple Comparison Test. p-value 
of <0.05 were considered statistically significant. 
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Results 
We designed the experiment with 50 animals, 10 of them died during or 
after surgery (2 per group). Necropsies showed that pulmonary embolism, 
bleeding from the arterial incision and neurological deficits were the cause, these 
animals were not replaced and the experiment was completed with the remaining 
animals.  
Physiological variables are presented on Table 4. The mean arterial 
pressure combining all the injured groups before the insult was 110, during the 
insult the mean arterial pressure was 27 and after the blood was reinfused the 
MAP was 87. We did not find any statistically significant differences between the 
pre-operative values and the post-operative values. Normal animals with no 
injury, gained an average of 24 grams in two weeks, the animals that received 
the insult gained an average of 25 grams in the same period; the animals that 
received the insult plus were treated with isoflurane 90 minutes after the insult, 
gained 8 grams in average. Statistically we did not find any significant difference. 
The animals that received the insult have lower weight at day 1 and 4 after the 
injury but by day 14 the weight was comparable with the control animals. The 
mean hemoglobin saturation during the episode measured immediately before 
the hypotensive insult was 74.2; the values before and after the insult were 94.8 
and 95.5 respectively. No significant changes in temperature and heart rate were 
found. 
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Table 4. Values are mean ± SD. MAP = Mean Arterial Pressure, HR = Heart 
rate, To = Temperature, bpm = Bits Per Minute, Hb = Hemoglobin, F°= 
Fahrenheit. 
 
Neurological performance was evaluated in all animals and assigned a value in a 
neurological score, see Figure 1. Behavior measurements on postoperative day 
1, 4 and 14 were evaluated; the groups evaluated were: in group 1 are all the 
animals with the sham surgery that received no insult; in group 2 we have the 
animals that received the insult and were euthanized at day 14 and group 3 is the 
group that received the insult and also were treated with isoflurane 90 minutes. 
No statistically significant changes were found. (p > 0.05). It is important to 
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mention that some animals also showed some degree of paralysis after the 
surgery but by the time of the neurological evaluation it was no longer present.  
 
 
Figure 1. Neurological score. The figure shows small and non-significant 
changes in the neurological score. Only the groups euthanized at day 14 
were subject of neurological evaluation.  
 Passive avoidance as described by Saporta (18), was used to tested the 
ability to recall new memories. There was a statistically significant difference in 
memory during the two week period this difference was more evident at day 7 
and persisted at day 14 demonstrating that profound hypotension plus hypoxia 
for short periods of time can impair the creation of new memories. Animals 
treated with isoflurane after the insult did no show any memory impairment.  
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Figure 2. Passive avoidance. There is a statistically significant difference 
between groups 1 and 2 and 2 and 3. There is no statistically significant 
difference between groups 1 and 3.  
 Stereology was used to estimate the total number of positive NeuN cells in 
the CA1 area of the hippocampus. No difference in cell numbers were seen 
between control rats and rats that received 3 minutes of profound hypotension 
plus hypoxia at any time point (p > 0.05).  
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Figure 3. NeuN positive cells in animals subject to 3 min of 
hypotension/hypoxia. No statistically significant changes were found. 
Similar number of cells were found at all the time points analyzed.  
 Nissl stained cells in the CA1 area of the hippocampus were counted and 
although we found a pattern of decrease in the number of cells (see day 14) , 
there were no statistically significant changes at any time point after the 
hypotension plus hypoxia insult.  
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Figure 4. Nissl cells in CA1 area two weeks after the insult. No significant 
changes in the number of cells in the CA1 area of the hippocampus were 
found. 
 
Discussion: 
Although this model of insult is a temporary model (3 minutes of 
hypotension plus 8 minutes of hypoxia), we occluded the two common carotid 
arteries making it a model of constant hypoperfusion or global ischemia. 
However, even with this permanent ischemia, we did not find changes in the CA1 
area. 
Weight is always a good indicative of general conditions, normal animals 
increase in weight day after day; animals that received the insult lost a 
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statistically significant amount of weight after the insult but by day 14 this 
difference vanish among the groups. 
Oxygen saturation was recorded with a pulse-oximeter and maintained at 
an average of 74.2 + 6.6 assuring that although we used a facial mask for 
administration the mixture of 12% oxygen plus 88% nitrogen was effective in 
diminishing the saturation levels. 
Between 8 to 15 milliliters of blood were taken from the animal to 
decrease the blood pressure to a mean of 27.1 + 5.4. In previous experiments we 
have used lower MAP (below 20) (22) but in a preliminary study using that 
hypotension plus hypoxia the mortality was too high, for this reason we 
maintained a higher MAP (MAP < 30). 
Temperature is a well known factor in neuroprotection, the results showed 
that the heated pad is a good device to control this variable. The temperature at 
the beginning of the surgery was 95.5 + 2.9 and 93.5 + 1.6 at the end of the 
surgery. 
Neurological scale evaluation showed some negative effects related to the 
procedure but statistically results were not significant. Palpebral ptosis was the 
main motor alteration we found. In humans the dissection of the Internal carotid 
artery, typically manifests as an oculo-sympathetic palsy (myosis and palpebral 
ptosis)(23). 
Passive avoidance was used to test anterograde memories and a 
negative effect was seen one week after the insult, this memory deficiency 
persisted at two weeks after the insult. In a recent paper Bekker et al; found 
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impairment after hypotension in long term associative memory (3). Although we 
did not use the same model of hypotension and we also added hypoxia, the 
present study may highlight a similar mechanism. This memory deficit was 
reverse by the use of isoflurane per 90 minutes after the insult. 
Shutz et al; have demonstrated that hemorrhagic hypotension does not 
cause structural damages but can cause cognitive alterations (11). Our study 
showed a similar result, we found long-term (2 weeks) memory impairment 
without neurological changes or histological changes in the hippocampus.  
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CONCLUSIONS: 
Ischemia seems to be the cause of several disabilities and even death 
after surgical procedures. In the quest for options to manage it several variables 
have been studied with mixed results. Among them are hypothermia, 
hyperthermia, hyperoxemia, hyperglycemia, hyperventilation, etc. 
Pharmacological agents have been used for these purposes in animals and in 
humans with better results in the animals. Under specific conditions anesthetics 
have shown to have a neuroprotective effect but they do not work equally well in 
different models of ischemia (1).  
The main objective of this research project was to test the neuroprotective 
effect of anesthetics in different models of cerebral ischemia. The results of our 
first study indicate that the combination of Isoflurane plus repeated administration 
of a caspase 3 inhibitor (Z-DEVD-FMK) reduces the infarct size. We also 
observed a clear pattern of improvement with the use of Propofol in combination 
with Z-DEVD-FMK but it was not statistically significant. A similar but weaker 
protective pattern was found with the use of the caspase inhibitor by itself but the 
difference was not significant either. It is possible that by using a bigger sample 
size these patterns could reach significance.  
It seems clear that in a model of focal ischemia combined with mild global 
ischemia (middle cerebral artery occlusion plus common carotid artery occlusion) 
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the combination of volatile anesthetics with other pharmacological agents like 
caspase inhibitors is necessary to achieve a sustained protection (two weeks) 
(2). The positive results found with Isoflurane plus Z-DEVD-FMK confirmed that 
the apoptotic cascade is activated during the ischemic event and interventions 
directed to block apoptosis are possible targets of pharmacologic agents.  
The synergistic effect of anesthetics plus caspase inhibitors has been 
demonstrated by other researchers (3,4), and our results confirmed the 
effectiveness of the combination. 
Although the administration of Z-DEVD-FMK was done intraperitoneally 
the caspase inhibitor reached intracerebral targets. We believe that the caspase 
inhibitor got access to the apoptotic neurons thanks to the disruption of the 
blood-brain barrier due to the ischemic insult.  
We found a significant decrease in the number of Tunel positive cells in 
the brains of the animals that received the caspase inhibitor and in order to 
confirm that this effect was related to the intraperitoneal administration of the 
caspase inhibitor, we counted the cells that were positive for cleaved caspase 3. 
These results were consistent with the Tunel results and showed that animals 
that received the intraperitoneal injection had an important decrease in the 
number of apoptotic cells. We demonstrated that systemic administration of the 
caspase inhibitors is effective and can be used for the treatment of ischemic 
events in animal models. 
Histological improvement was consistent with neurological performance at 
four days after the insult; animals treated with anesthetics plus Z-DEVD-FMK 
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showed a significant improvement in comparison with the animals that did not 
receive the combination. By day 14 all the animals showed an important 
improvement. We believe that the scale used was not sensitive enough to pick 
some of the alterations that were present at two weeks after the insult. A more 
comprehensive scale is necessary to have a better understanding of the 
neurological outcome: for this reason, recently a 48 point scale was developed 
by connecting together several neurological scales making a more specific and 
reliable scale to measure neurological performance (5). 
It is clear now that anesthetics alone can also be protective and that this 
protection is sustained for long periods of time in models of focal ischemia(6). 
Protection is evident in models of global ischemia only for short periods of 
time(7). Since we occluded the middle cerebral artery and also the common 
carotid artery, we created a mixed model of focal and global ischemia; 
furthermore, the fact that anesthetics alone did not work could be explained for 
the global ischemic effect created by the blockage of the common carotid artery. 
In addition, it is also known that Isoflurane activates caspase 3 (8) and this is 
probably at least part of the reason for the lack of effectiveness of Isoflurane in 
models of global ischemia.  
In our work we used a caspase 3 inhibitor because it is part of the 
common pathway in the apoptotic cascade, and we believe that blocking only the 
intrinsic or extrinsic apoptotic pathway is less effective than blocking the common 
pathway. In addition, the caspase 3 inhibitor can also block the caspase 3 
activating effect of the Isoflurane granting a more potent neuroprotection. 
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In the bibliography, hypothermia has been reported to be an important 
neuroprotective influence(1). In our study we controlled temperature to prevent 
bias. To prevent a hypothermic state in our animals a heated pad was placed 
underneath the rat. There were not significant changes in the initial and final 
temperature. The mean initial body temperature was 93.5 + 3 and the final was 
90 + 4.4. Although the temperature was lower than the normal, there are no 
statically significant differences in between the groups. We are confident that the 
results we obtained were not influenced by hypothermia since all the groups 
showed similar values. 
Monitoring other parameters like arterial blood gases and glycemia was 
also important. We did not control these variables because of technical difficulties 
but it is highly recommended to consider these parameters to be able to attribute 
the results to the actual treatment been evaluated and not to external factors that 
were not considered in the study. 
In our experiments after collecting the brains we reviewed the placement 
of the filament in the middle cerebral artery. We found that in a few cases the 
filament moved. Therefore, we consider that, the filament approach to occlusion 
of the middle cerebral artery is better for temporary focal ischemia rather than 
permanent ischemia. For permanent blockage of the middle cerebral artery the 
use of craniotomy and direct cauterization of the artery is recommended. This 
allows the surgeon to insure that the artery will remain closed and permanent 
focal ischemia will follow. 
After finding the neuroprotective effect of anesthetics in combination with 
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caspase inhibitors in the previous animal model, we decided to look for another 
model of ischemia to verify the neuroprotective effect of anesthetics. We found 
that anesthesiologists were divided regarding the issue of continuous monitoring 
of arterial blood pressure during surgery. The group in favor of direct arterial 
pressure monitoring believe that even a short period of hypotension not detected 
by traditional monitoring methods, can be the origin of conditions like post 
operative cognitive dysfunction. With that idea in mind we decided to study a 
model of profound hypotension for short periods of time.  
Initially the use of nitroprusside seemed to be the logical as the 
hypotensive agent. However, after a pilot study with mixed results and 
uncertainty whether the results were related to hypotension or the cyanide 
released as a principal metabolite of nitroprusside; we opted for a bleeding 
induced hypotension model. In a pilot study we tested one, two and three 
minutes of profound hypotension (Mean Arterial Blood Pressure below 20) and 
we did not find any changes either in the cortex nor in the hippocampus with only 
one or two minutes of hypotension. In the three minutes of hypotension group, 
we found fluoro jade C positives cells in cortex and hippocampus. Because of 
these findings we decided to conduct a study to detect if those changes were 
maintained.  
Our observations evidenced that repeated hypotensive episodes lead to 
hippocampal damage. Our results suggest that in this rat hemorrhagic model, 
brief periods of hypotension result in neuronal damage in the hippocampal CA1 
region one day after the insult. By day 14, surviving cells are significantly 
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reduced in number in the hippocampus. We did not find any significant changes 
in cortical cell numbers. We believe that more studies are necessary to elucidate 
subtler effects of apparently innocuous periods of hypotension may not be 
accurately detected by indirect blood pressure monitoring. 
We evaluated the changes in weight in all the groups and there was not a 
significant change. We believe that although the animals showed some 
histological changes in the CA1 area of the hippocampus the damage was not 
sufficient to induce weight changes two weeks after the injury. Although short 
periods of profound hypotension may not alter general conditions, they can be 
implicated in damage to very sensitive cells. More research is necessary to show 
whether those changes are limited to the brain or if other organs are affected.  
In our experimental model 8 cc to 12 cc of blood were removed each time 
to achieve a mean arterial blood pressure below 20. The mean arterial blood 
pressure for all the groups at the beginning of the hypotensive period was 19.2 + 
1.1. Yamauchi, et al (9,10) found histopathological changes after one week in the 
hippocampus with a MAP of 25 with 2 or 3 minutes of hypotension. In our 
experience these changes continue to be present two weeks after the insult. Our 
findings support previous data that showed deleterious effects of short periods of 
hypotension. We found damages in the hippocampus and since this structure is 
part of the machinery involved in creating memories, there is a possibility that 
short periods of hypotension could explain cognitive impairment seen after 
surgery in some patients. 
   120 
The forty-eight point neurological scale did not show any statistically 
significant changes. Interestingly we found temporal motor paralysis in the upper 
body that lasted only few hours. By the time of the neurological evaluation, the 
paralysis was gone and could not be recorded as a positive finding. A common 
finding after 24 hours of recovery was palpebral ptosis but statistically this finding 
was not significant. In all the cases where palpebral ptosis was found, recovery 
was complete by day 4. In humans the dissection of the Internal carotid artery, 
typically manifests as an oculo-sympathetic palsy (myosis and palpebral 
ptosis)(11), we placed the catheters in the common carotid artery but since the 
surgical area is small, it is possible that we had manipulated the internal carotid 
artery leading to this finding. 
The passive avoidance paradigm is used for memory evaluation (12); 
Bekker et al. (2009)  have demonstrated using this paradigm that hypotension 
can cause disruption in consolidation of long term memory (13). In the present 
study we did not find any memory alterations. We hypothesize that this difference 
is due to either the type of hypotension (they used nitroglycerine and we 
withdrew the blood) or the other important difference is the timeline of the 
hypotensive period. Bekker caused the hypotension early after the learning; in 
fact the latest injection was given 3 hours after the training. In our study we 
trained the animals 24 hours before the surgery and tested 24 hours after the 
surgery giving them enough time to consolidate their memories. Our study 
demonstrated that although there is damage in the hippocampus after 3 separate 
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periods of profound hypotension, memories that are already consolidated were 
not affected.  
We used fluoro jade C to evaluate brains on 1, 4 and 14 days after 
hypotension. We found a significant difference in the in the number of fluoro jade 
c positive cells in the frontal cortex at day 1. Cells were counted using an 
automatic method as previously described (14). However this significant 
difference was not evident when stereology was used. Results found in Fluoro 
jade c cells at day one in the CA1 hippocampal area were significant with the two 
methods. We concluded that one day after repetitive periods of hypotension 
there is brain damage that can persist after 2 weeks. Although the number of 
affected cells in cortex did not reach significance, we believe that the presence of 
these fluoro jade positive cells is important and should be considered; since the 
numbers were close to significant and is possible that by using more animals 
numbers can reach significance. 
After finishing with this experiment we believed that although there was 
some degree of damage, it was possible that the model was not severe enough 
to test the efficacy of anesthetics as neuroprotective agents. For this reason we 
decided to conduct another study with a stronger insult in order to create more 
damage and in this way be able to test the effect of anesthetics in a new model. 
We developed a model of profound hypotension similar to the one previously 
used; but instead of using one minute every hour during two hours for a total of 
three episodes of hypotension, we used three consecutive minutes of 
hypotension combined with eight minutes of hypoxia. After the insult we exposed 
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the animals to Isoflurane for ninety minutes to evaluate its effect.  
We believed that because the insult was longer, the damage should be 
greater, we were surprised we did not find any histological damage at any of the 
time points analyzed (1 day, 4 days and 14 days). The histology was done using 
NeuN staining.  NeuN was used because it is specific for neurons and should 
improve the counting methods. When we realized that no changes were found 
and taking into consideration that in the previous study we had found changes 
with the Nissl staining, we decided to confirm our NeuN results with Nissl 
staining. Again no changes were seen. It is important to mention that we also 
stained the brains with fluoro jade C only in the animals that were sacrificed at 
day one and compared those results with control animals to see if any damage 
was evident, but again no changes were seen. We did not show the fluoro jade c 
results in here because not all groups were represented. Our theory is that to be 
able to cause some damage in the brain it is necessary to have repetitive insults; 
one insult was not capable of causing histological changes. 
A closer look at the data shows that in this experiment we did achieve a 
mean arterial pressure (MAP) below 20 as used in our previous study and as 
used by other researchers (14). In a preliminary study using hypotension with a 
mean arterial pressure below 20 plus hypoxia, the mortality was too high (80%), 
for this reason we maintained a higher MAP (MAP < 30). It is possible that this is 
a determining factor that can be responsible for the unexpected results.  
The neurological scale showed some impairments related to the 
procedure but statistically the results were not significant. This is not surprising 
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since histological evaluation of one of the most ischemia sensible areas of the 
brain was not affected. Palpebral ptosis was the main motor alteration we found; 
again possibly related to the dissection of the Internal carotid artery, which 
manifests as an oculo-sympathetic palsy in humans (myosis and palpebral 
ptosis)(11).  
Passive avoidance was used to test anterograde memories and a 
negative effect was seen. In a recent paper Bekker et al (2009); found 
impairment after hypotension in long term associative memory (13). Although we 
did not use the same model of hypotension and we also added hypoxia, the 
present study may highlight a similar mechanism. Other investigations have 
demonstrated that hemorrhagic hypotension does not cause structural damages 
but can cause cognitive alterations (15). Our study showed a similar result, we 
found long-term (2 weeks) memory impairment without neurological changes or 
histological changes in the hippocampus. What we find interesting is the fact that 
using Isoflurane for 90 minutes after the insult could reverse the memory 
changes seen with a single episode of hypotension plus hypoxia.  
We concluded that a single episode of hypotension and hypoxia is not 
enough to cause histological changes in the CA1 hippocampal area but it is 
enough to cause memory changes that can be reversed with the use of 
isoflurane. 
As a general conclusion we demonstrated that anesthetics have a 
neuroprotective effect. They act in different ways accordingly to the insult that 
caused the injury and in some cases they need coadjuvants to exert its beneficial 
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effect. In the first experiment, neither isoflurane and propofol showed any long 
lasting protective effect by themselves, nor the coadjuvant drug alone, but the 
combination was neuroprotective. In the second case although there were not 
histological changes there were memory changes that were prevented by the use 
of only anesthetics.  
   125 
References: 
1. Fukuda S, Warner DS. Cerebral protection. Br J Anaesth 2007;99:10-7. 
 
2. Inoue S, Drummond JC, Davis DP, Cole DJ, Patel PM. Combination of 
isoflurane and caspase inhibition reduces cerebral injury in rats subjected 
to focal cerebral ischemia. Anesthesiology 2004;101:75-81. 
 
3. Inoue S, Davis DP, Drummond JC, Cole DJ, Patel PM. The combination of 
isoflurane and caspase 8 inhibition results in sustained neuroprotection in 
rats subject to focal cerebral ischemia. Anesth Analg 2006;102:1548-55. 
 
4. Jin K GS, Mao X, et al.   2001;21:1411–21. Fas (CD95) may mediate 
delayed cell death in hippocampal CA1 sector after global ce- rebral 
ischemia. J Cereb Blood Flow Metab 2001;21:1411–21. 
 
5. Yokoo N, Sheng H, Mixco J, Homi HM, Pearlstein RD, Warner DS. 
Intraischemic nitrous oxide alters neither neurologic nor histologic 
outcome: a comparison with dizocilpine. Anesth Analg 2004;99:896-903, 
table of contents. 
6. Sakai H, Sheng H, Yates RB, Ishida K, Pearlstein RD, Warner DS. 
Isoflurane provides long-term protection against focal cerebral ischemia in 
the rat. Anesthesiology 2007;106:92-9; discussion 8-10. 
 
   126 
7. Elsersy H, Sheng H, Lynch JR, Moldovan M, Pearlstein RD, Warner DS. 
Effects of isoflurane versus fentanyl-nitrous oxide anesthesia on long-term 
outcome from severe forebrain ischemia in the rat. Anesthesiology 
2004;100:1160-6. 
 
8. Zhang G, Dong Y, Zhang B, Ichinose F, Wu X, Culley DJ, Crosby G, Tanzi 
RE, Xie Z. Isoflurane-induced caspase-3 activation is dependent on 
cytosolic calcium and can be attenuated by memantine. J Neurosci 
2008;28:4551-60. 
 
9. Yamauchi Y, Kato H, Kogure K. Brain damage in a new hemorrhagic 
shock model in the rat using long-term recovery. J Cereb Blood Flow 
Metab 1990;10:207-12. 
 
10. Yamauchi Y, Kato H, Kogure K. Hippocampal damage following repeated 
brief hypotensive episodes in the rat. J Cereb Blood Flow Metab 
1991;11:974-8. 
11. Eschmann L, Favrat B, Botez S, Wuerzner K. [Partial Horner's syndrome 
and facial pain: a diagnosis one should not miss]. Rev Med Suisse 
2006;2:544-6. 
 
12. Saporta S, Borlongan CV, Sanberg PR. Neural transplantation of human 
neuroteratocarcinoma (hNT) neurons into ischemic rats. A quantitative 
   127 
dose-response analysis of cell survival and behavioral recovery. 
Neuroscience 1999;91:519-25. 
 
13. Bekker A, Haile M, Li YS, Galoyan S, Garcia E, Quartermain D, Kamer A, 
Blanck T. Nimodipine prevents memory impairment caused by 
nitroglycerin-induced hypotension in adult mice. Anesth Analg 
2009;109:1943-8. 
 
14. Rafael E. Chaparro MD, Carolina E. Quiroga, M.D., M.B.A., Rachel 
Karlnoski, Ph.D., Devanand Mangar, M.D., Enrico Camporesi, M.D. Brief 
systemic hypotension results in cortical neuronal loss in Sprague Dawley 
rats. American Society of Anesthesiology. Orlando, 2008. 
 
15. Schutz C, Stover JF, Thompson HJ, Hoover RC, Morales DM, Schouten 
JW, McMillan A, Soltesz K, Motta M, Spangler Z, Neugebauer E, McIntosh 
TK. Acute, transient hemorrhagic hypotension does not aggravate 
structural damage or neurologic motor deficits but delays the long-term 
cognitive recovery following mild to moderate traumatic brain injury. Crit 
Care Med 2006;34:492-501. 
 
 
  
 
 
ABOUT THE AUTHOR 
 
Rafael Eduardo Chaparro received his Medical Doctor degree from the Pontificia 
Universidad Javeriana in Bogota-Colombia in 1996; he then worked in 
Colombian rural areas serving communities and for the Colombian Army. In 
2001, he received his first Master’s degree in Occupational Health Management 
from the Universidad del Rosario in Bogota and started a successful career in the 
Pharmaceutical Industry. He got married and moved to Tampa.  Right before 
entering the Ph.D. program at USF, Rafael worked at the Alzheimer’s disease 
Research Laboratory under the tutelage of Dr. Dave Morgan and Dr. Marcia 
Gordon. He got his second Master’s degree in Medical Sciences from the 
University of South Florida in 2008. His Ph.D. research focused on neuronal 
injury during anesthesia and neuroprotection with anesthetic agents; receiving 
three awards from national and international Anesthesia Societies. He 
successfully defended his doctoral dissertation in April 2010 at the University of 
South Florida. 
